پرش به محتوا

فلوبرومازولام

از ویکی‌پدیا، دانشنامهٔ آزاد
فلوبرومازولام
وضعیت قانونی
وضعیت قانونی
  • CA: رده چهار
  • UK: PSA
  • US: The DEA has announced intent to place Flubromazolam under control in Schedule I [۱]
  • Illegal in Sweden and Switzerland
شناسه‌ها
  • 8-bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a] [1,4]benzodiazepine
شمارهٔ سی‌ای‌اس
پاب‌کم CID
کم‌اسپایدر
UNII
CompTox Dashboard (EPA)
داده‌های فیزیکی و شیمیایی
فرمول شیمیاییC17H12BrFN4
جرم مولی۳۷۱٫۲۱۳ g·mol−1
مدل سه بعدی (جی‌مول)
  • BrC1=CC3=C(C=C1)[N]2C(=NN=C2C)CN=C3C4=C(C=CC=C4)F
  • InChI=1S/C17H12BrFN4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3 N
  • Key:VXGSZBZQCBNUIP-UHFFFAOYSA-N N
 N✔Y (این چیست؟)

فلوبرومازولام (انگلیسی: Flubromazolam)[۲][۳][۴] یک تریازولوبنزودیازپین (TBZD) و از مشتقات بنزودیازپین (BZD) است. فلوبرومازولام به علت قدرت بالا ممکن است خطرات نسبتاً بالاتری نسبت به سایر بنزودیازپین‌های طراح داشته باشند، به دلیل توانایی آنها در ایجاد آرامبخشی قوی و فراموشی داشته باشد.[۵][۶][۷][۸][۹][۱۰][۱۱]

جستارهای وابسته

[ویرایش]

منابع

[ویرایش]
  1. "(Proposed Rule) Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I". Drug Enforcement Administration. December 23, 2022.
  2. Cook JM, et al. Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects. US7618958
  3. Borer, René; Gerecke, Max; Kyburz, Emilio (22 October 1986). "Patent EP 0072029 B1 - Triazolobenzazepines, process and intermediates for their preparation and medicines containing them". Retrieved 6 August 2015.
  4. Hester JB, Rudzik AD, Kamdar BV (November 1971). "6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines which have central nervous system depressant activity". Journal of Medicinal Chemistry. 14 (11): 1078–81. doi:10.1021/jm00293a015. PMID 5165540.
  5. "Flubromazolam". Cayman Chemical. Retrieved 20 November 2015.
  6. Huppertz LM, Bisel P, Westphal F, Franz F, Auwärter V, Moosmann B (July 2015). "Characterization of the four designer benzodiazepines clonazolam, deschloroetizolam, flubromazolam, and meclonazepam, and identification of their in vitro metabolites". Forensic Toxicology. 33 (2): 388–395. doi:10.1007/s11419-015-0277-6. S2CID 33278305.
  7. Chaslot M, El Balkhi S, Robin T, Morichon J, Picard N, Saint-Marcoux F (June 2016). "Exploration des métabolites de 8 benzodiazépines de synthèse". Toxicologie Analytique et Clinique. 28 (2): S32. doi:10.1016/j.toxac.2016.03.053.
  8. Pettersson Bergstrand M, Helander A, Hansson T, Beck O (April 2017). "Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays". Drug Testing and Analysis. 9 (4): 640–645. doi:10.1002/dta.2003. PMID 27366870.
  9. Høiseth G, Tuv SS, Karinen R (November 2016). "Blood concentrations of new designer benzodiazepines in forensic cases". Forensic Science International. 268: 35–38. doi:10.1016/j.forsciint.2016.09.006. PMID 27685473.
  10. Manchester KR, Maskell PD, Waters L (March 2018). "Experimental versus theoretical log D7.4, pKa and plasma protein binding values for benzodiazepines appearing as new psychoactive substances" (PDF). Drug Testing and Analysis. 10 (8): 1258–1269. doi:10.1002/dta.2387. PMID 29582576.
  11. Wohlfarth, Ariane; Vikingsson, Svante; Roman, Markus; Andersson, Mikael; Kugelberg, Fredrik C.; Green, Henrik; Kronstrand, Robert (May 2017). "Looking at flubromazolam metabolism from four different angles: Metabolite profiling in human liver microsomes, human hepatocytes, mice and authentic human urine samples with liquid chromatography high-resolution mass spectrometry". Forensic Science International. Special Issue on the 54th Annual Meeting of the International Association of Forensic Toxicologists (TIAFT) Brisbane from August 28 to September 1, 2016. 274: 55–63. doi:10.1016/j.forsciint.2016.10.021. ISSN 0379-0738. PMID 27863836.